메뉴 건너뛰기




Volumn 62, Issue 6, 2010, Pages 509-515

Short-term effect of an estroprogestin containing ethinyl-estradiol 20 mcg + drospirenone 3 mg in 24+4 regimen at hormonal and cutaneous level in ovarian hyperandrogenism;Effetto a breve termine di un estroprogestinico contenente etinilestradiolo 20 mcg+drospirenone 3 mg in schema 24 + 4 a livello ormonale e cutaneo nell'iperandrogenismo ovarico

Author keywords

Acne vulgaris; Drospirenone; Estroprogestin; Hyperandrogenism

Indexed keywords

ANDROSTENEDIONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; EPIANDROSTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; ALDOSTERONE ANTAGONIST; ANDROSTANE DERIVATIVE; DROSPIRENONE; ESTROGEN; ESTROGEN PROGESTAGEN; ETHINYLESTRADIOL; PREGNANE DERIVATIVE;

EID: 79952219373     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (20)
  • 2
    • 34547564845 scopus 로고    scopus 로고
    • Dermatologic manifestations of polycystic ovary syndrome
    • DOI 10.2165/00128071-200708040-00003
    • Lee AT, Zane LT. Dermatologic manifestations of polycystic ovary syndrome. Am J Clin Dermatol 2007;8:201-19. (Pubitemid 47195665)
    • (2007) American Journal of Clinical Dermatology , vol.8 , Issue.4 , pp. 201-219
    • Lee, A.T.1    Zane, L.T.2
  • 5
    • 0346725827 scopus 로고    scopus 로고
    • Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
    • (2004) Fertil Steril , vol.81 , pp. 19-25
  • 7
    • 0036547728 scopus 로고    scopus 로고
    • The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea
    • van Vloten WA, van Haselen CW, van Zuuren EJ, Gerlinger C, Heithecker R. The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis 2002;69:2-15.
    • (2002) Cutis , vol.69 , pp. 2-15
    • Van Vloten, W.A.1    Van Haselen, C.W.2    Van Zuuren, E.J.3    Gerlinger, C.4    Heithecker, R.5
  • 8
    • 33847027994 scopus 로고    scopus 로고
    • Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism
    • Batukan C, Muderris H, Ozcelik B, Ozturk B, Ozturk A. Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism. Gynecol Endocrinol 2007;23:38-44.
    • (2007) Gynecol Endocrinol , vol.23 , pp. 38-44
    • Batukan, C.1    Muderris, H.2    Ozcelik, B.3    Ozturk, B.4    Ozturk, A.5
  • 9
    • 64349093259 scopus 로고    scopus 로고
    • Effects of two estroprogestins containing ethynilestradiol 30 mg and drospirenone 3 mg and ethynilestradiol 30 mg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
    • Lello S, Primavera G, Colonna L, Vittori G, Guardianelli F, Sorge R et al. Effects of two estroprogestins containing ethynilestradiol 30 mg and drospirenone 3 mg and ethynilestradiol 30 mg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations. Gynecol Endocrinol 2008;24:718-23.
    • (2008) Gynecol Endocrinol , vol.24 , pp. 718-723
    • Lello, S.1    Primavera, G.2    Colonna, L.3    Vittori, G.4    Guardianelli, F.5    Sorge, R.6
  • 10
    • 40649128938 scopus 로고    scopus 로고
    • Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: A randomized, double-blind, placebo-controlled trial
    • Koltun W, Lucky AW, Thiboutot D, Niknian M, Sampson-Landers C, Korner P et al. Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial. Contraception 2008;77:249-56.
    • (2008) Contraception , vol.77 , pp. 249-256
    • Koltun, W.1    Lucky, A.W.2    Thiboutot, D.3    Niknian, M.4    Sampson-Landers, C.5    Korner, P.6
  • 11
    • 55449126686 scopus 로고    scopus 로고
    • Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen. A randomized controlled trial
    • Maloney JM, Dietze P Jr, Watson D, Niknian M, Lee-Rugh S, Sampson-Landers C et al. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen. A randomized controlled trial. Obstet Gynecol 2008;112:773-81.
    • (2008) Obstet Gynecol , vol.112 , pp. 773-781
    • Maloney, J.M.1    Dietze Jr., P.2    Watson, D.3    Niknian, M.4    Lee-Rugh, S.5    Sampson-Landers, C.6
  • 13
    • 0031154916 scopus 로고    scopus 로고
    • A comparison of current acne grading systems and proposal of a novel system
    • Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol 1997;36:416-8.
    • (1997) Int J Dermatol , vol.36 , pp. 416-418
    • Doshi, A.1    Zaheer, A.2    Stiller, M.J.3
  • 15
    • 27744554128 scopus 로고    scopus 로고
    • Drospirenone in combination with estrogens: For contraception and hormone replacement therapy
    • DOI 10.1080/13697130500330341
    • Oelkers WH. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Climacteric 2005;3:19-27. (Pubitemid 41608060)
    • (2005) Climacteric , vol.8 , Issue.SUPPL. 3 , pp. 19-27
    • Oelkers, W.H.K.1
  • 17
    • 0028945947 scopus 로고
    • Impaired water barrier function in acne vulgaris
    • Yamamoto A, Takenouchi K, Ito M. Impaired water barrier function in acne vulgaris. Arch Dermatol Res 1995;287:214-8.
    • (1995) Arch Dermatol Res , vol.287 , pp. 214-218
    • Yamamoto, A.1    Takenouchi, K.2    Ito, M.3
  • 18
    • 0015187928 scopus 로고
    • The effect of oestrogenic treatment on the acid mucopolysaccaride pattern in skin of mice
    • Grosman N, Hvidberg E, Schou J. The effect of oestrogenic treatment on the acid mucopolysaccaride pattern in skin of mice. Acta Pharmacol Toxicol 1971;30:458-64.
    • (1971) Acta Pharmacol Toxicol , vol.30 , pp. 458-464
    • Grosman, N.1    Hvidberg, E.2    Schou, J.3
  • 19
    • 0018837325 scopus 로고
    • The mechanism of estrogen-induced increase in hyaluronic acid biosynthesis, with special reference to estrogen receptor in the mouse skin
    • Uzuka M, Nakajima K, Ohta S, Mori Y. The mechanism of estrogen-induced increase in hyaluronic acid biosynthesis, with special reference to estrogen receptor in the mouse skin. Biochim Biophys Acta 1980;627:199-206.
    • (1980) Biochim Biophys Acta , vol.627 , pp. 199-206
    • Uzuka, M.1    Nakajima, K.2    Ohta, S.3    Mori, Y.4
  • 20
    • 0029156254 scopus 로고
    • Skin water-holding capacity and transdermal estrogen therapy for menopause: A pilot study
    • Pierard-Franchimond C, Letane C, Goffin V, Pierard GE. Skin water-holding capacity and transdermal estrogen therapy for menopause: a pilot study. Maturitas 1995;22: 151-4.
    • (1995) Maturitas , vol.22 , pp. 151-154
    • Pierard-Franchimond, C.1    Letane, C.2    Goffin, V.3    Pierard, G.E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.